Title: Immunity to Infectious Diseases
1Immunity to Infectious Diseases
0
- BIOS 486A/586A
- K.J.Goodrum 2006
2Topic Outline
0
- Routes and sites of infection
- Mechanisms of tissue injury in infection
- Timing of immune responses to infection
- Regulation of cell-mediated (TH1) vs. humoral
immunity (TH2) in infections - Effector mechanisms for immunity to different
pathogens - Microbial evasion of immune responses
- Immunizations/vaccines
3Routes and sites of infection
0
40
Primary Route of Infection Microbial Adherence
and Invasion of epithelial tissues (lung, gut,
other)
Janeway, Fig. 10.2
50
Primary Route of Infection Microbial Adherence
and Invasion of epithelial tissues (continued).
Janeway, Fig. 10.2
60
Janeway. Fig. 10.4. Infection compartments
7Mechanisms of tissue injury in infection
0
80
Janeway. Fig. 10.5. Mechanisms of
Pathogen-induced tissue Damage
90
Janeway. Fig. 10.5. Mechanisms of
Pathogen-induced tissue Damage (continued)
10Timing of immune responses to infection
0
110
Janeway. Fig. 10.1. Time course of immune
response to acute infection.
12Regulation of cell-mediated (TH1) vs. humoral
immunity (TH2) in infections
0
130
Janeway. Fig.10.9. Infection induced Th1 vs. Th2
responses.
140
Janeway. Fig. 11.6. The effect of T helper
subpopulations on leprosy outcome.
150
Janeway. Fig. 11.6. The effect of T helper
subpopulations on leprosy outcome. (continued)
16Effector mechanisms for immunity to different
pathogens
0
170
Janeway. Fig. 10.17. Protective Effector
Mechanisms against various infectious microbes
180
Janeway. Fig. 10.17. Protective Effector
Mechanisms against various infectious microbes
(continued)
190
Janeway. Fig. 10.17. Protective Effector
Mechanisms against various infectious microbes
(continued)
200
Janeway. Fig. 10.23. Mucosal gdT cell function.
210
Janeway. Fig. 10.24. Mucosal Secretory IgA
function
220
Janeway. Fig. 10.27. Recognition of intracellular
infection by Nod1.
230
Janeway. Fig. 10.27. Recognition of intracellular
infection by Nod1.(continued)
240
Janeway. Fig. 2.5. Innate recognition of microbes
and phagocytosis by macrophages
250
Janeway. Fig. 2.18. Microbial activation of
complement pathways for inflammation.
260
Janeway. Fig. 9.1. Protective effector mechanisms
of antibody.
270
Janeway. Fig. 1.24 Protective effector mechanisms
of antibody.
280
Janeway. Fig. 8.27. Effector T cell populations
and effector mechanisms.
29Microbial evasion of immune responses
0
300
Janeway. Fig. 11.1. Immune evasion via multiple
antigenic variants of microbes (serotypes).
310
Fig.11.1 continued
320
Fig. 11.1 continued
330
Janeway. Fig. 11.2. Immune Evasion via antigen
drift/shift.
340
Janeway. Fig. 11.2. Immune Evasion via antigen
drift/shift. (continued)
350
Janeway. Fig. 11.3. Immune evasion via sequential
DNA rearrangements of microbial antigens.
360
Janeway. Fig. 11.3. Immune evasion via sequential
DNA rearrangements of microbial antigens.
(continued)
370
Janeway. Fig. 11.5. Immune evasion mechanisms of
herpes viruses.
380
Janeway. Fig. 11.5. Immune evasion mechanisms of
herpes viruses. (continued)
390
Janeway. Fig. 11.5. Immune evasion mechanisms of
herpes viruses. (continued)
40Immunizations/vaccines
0
410
Janeway. Fig. 14.21. Childhood vaccination
schedule in USA.
420
Janeway. Fig. 14.23.
430
Janeway. Fig. 14.23. continued.
44Summary
0
- Immunity to infection depends on a combination of
innate mechanisms (phagocytosis, complement,
etc.) and antigen specific adaptive responses
(antibody, effector T lymphocytes). - The immune system regulates which specific
responses predominate (humoral vs. cell-mediated)
based on the body compartment infected
(intracellular vs. extracellular) and on cytokine
signals present at initial antigen contact (Th1
vs. Th2 responses).
45Summary-continued
0
- Disease-causing microbes have virulence
mechanisms that resist or evade innate and/or
specific immune effector functions. - Recovery from natural infection or artificial
immunization promote specific longterm immunity
to re-infection (immunological memory).